235 related articles for article (PubMed ID: 28747357)
41. Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts.
Xia S; Li X; Johnson T; Seidel C; Wallace DP; Li R
Development; 2010 Apr; 137(7):1075-84. PubMed ID: 20181743
[TBL] [Abstract][Full Text] [Related]
42. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
43. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
Belibi FA; Wallace DP; Yamaguchi T; Christensen M; Reif G; Grantham JJ
J Am Soc Nephrol; 2002 Nov; 13(11):2723-9. PubMed ID: 12397042
[TBL] [Abstract][Full Text] [Related]
44. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models.
Cao Y; Semanchik N; Lee SH; Somlo S; Barbano PE; Coifman R; Sun Z
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21819-24. PubMed ID: 19966229
[TBL] [Abstract][Full Text] [Related]
45. Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.
Hopp K; Hommerding CJ; Wang X; Ye H; Harris PC; Torres VE
J Am Soc Nephrol; 2015 Jan; 26(1):39-47. PubMed ID: 24994926
[TBL] [Abstract][Full Text] [Related]
46. Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.
Pinto CS; Reif GA; Nivens E; White C; Wallace DP
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1412-24. PubMed ID: 22952279
[TBL] [Abstract][Full Text] [Related]
47. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
48. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
[TBL] [Abstract][Full Text] [Related]
49. Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.
Li A; Xu Y; Fan S; Meng J; Shen X; Xiao Q; Li Y; Zhang L; Zhang X; Wu G; Liang C; Wu D
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515026
[TBL] [Abstract][Full Text] [Related]
50. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells.
Vekaria PH; Kumar A; Subramaniam D; Dunavin N; Vallurupalli A; Schoenen F; Ganguly S; Anant S; McGuirk JP; Jensen RA; Rao R
Leukemia; 2019 Jul; 33(7):1675-1686. PubMed ID: 30664664
[TBL] [Abstract][Full Text] [Related]
51. Triptolide reduces cystogenesis in a model of ADPKD.
Leuenroth SJ; Bencivenga N; Igarashi P; Somlo S; Crews CM
J Am Soc Nephrol; 2008 Sep; 19(9):1659-62. PubMed ID: 18650476
[TBL] [Abstract][Full Text] [Related]
52. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
Wu G
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
[TBL] [Abstract][Full Text] [Related]
53. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
54. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model.
Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y
Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways.
Zhang WB; Yang F; Wang Y; Jiao FZ; Zhang HY; Wang LW; Gong ZJ
Biomed Pharmacother; 2019 Sep; 117():109166. PubMed ID: 31255993
[TBL] [Abstract][Full Text] [Related]
56. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
[TBL] [Abstract][Full Text] [Related]
57. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
[TBL] [Abstract][Full Text] [Related]
58. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
Wang X; Harris PC; Somlo S; Batlle D; Torres VE
Nephrol Dial Transplant; 2009 Feb; 24(2):526-34. PubMed ID: 18826972
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
60. β3 adrenergic receptor as potential therapeutic target in ADPKD.
Schena G; Carmosino M; Chiurlia S; Onuchic L; Mastropasqua M; Maiorano E; Schena FP; Caplan MJ
Physiol Rep; 2021 Oct; 9(20):e15058. PubMed ID: 34676684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]